Pioneering the Future of Neurology: Bridging Research and Care with Digital Innovation Get Started Now!
Empowering Clinicians and Researchers with Digital Tools for Precise Dementia Diagnosis
More than 55 million people globally suffer from dementia, a number that is rapidly increasing due to the aging population. There is a lack of precise, scalable diagnostic methods. BraincheX, our cloud-based digital testing solution, delivers unprecedented precision in diagnoses, offering significant value to healthcare providers and the pharmaceutical industry.
We offer easily accessible digital cognitive tests for the early detection of cognitive decline and digital surveys for patient-reported outcomes.
Our aim is to make an early diagnosis of Alzheimer’s disease accessible, addressing underdiagnosis, and with novel therapeutics becoming increasingly available in more countries, maximizing the number of people who can benefit from these treatments.
Medotrax: Innovating Cognitive Testing and Surveys for Neurology
Medotrax specializes in delivering advanced digital solutions focused on cognitive testing and patient surveys to support clinical research and healthcare in neurology. Our product portfolio includes BraincheX, a state-of-the-art cognitive testing solution designed for early diagnosis of dementia, and a comprehensive range of digital surveys tailored for patient-reported outcomes. Together, these tools provide healthcare providers and researchers with precise, scalable assessments, enabling efficient data management and enhanced patient care across neurology studies.
Revolutionizing Cognitive Testing for Early Dementia Diagnosis
Medotrax's BraincheX is a state-of-the-art digital cognitive test solution designed for quick and easy administration, specifically targeting the early diagnosis of Alzheimer's disease. Utilizing advanced digital technology, BraincheX provides precise and reliable cognitive assessments, enabling healthcare providers to detect signs of cognitive decline early and streamline patient care. Our solution is also available as an iOS app, offering easy accessibility for clinicians and researchers.
Clinically Validated Digital Assessments:
Together with our clinical partners, we validate the performance of our digital dementia test solutions, ensuring accurate assessments and offering near-instant analytics for informed decision-making.
Gamified Experience:
Our cognitive tests are designed with gamification in mind, creating an engaging and interactive experience for users while delivering reliable assessments.
Inclusive and Accessible:
Our goal is to make digital assessments more accessible and inclusive for people with cognitive, motor or behavioral difficulties.
Language-Independent Testing:
We offer language-independent testing, ensuring that language barriers do not impede accurate assessments.
Comprehensive Cognitive Assessments:
Our cognitive tests are designed for quick assessments, covering all relevant cognitive domains to provide comprehensive and accurate evaluations.
Unlocking Real-World Neurological Insights Through Surveys
Medotrax BraincheX is at the forefront of making clinical assessments more inclusive and accessible. Our surveys, such as the Subjective Cognitive Decline Questionnaire (SCDQ), Depression Assessment, and medical conditions questionnaires, are meticulously designed to provide quick, actionable insights for research and healthcare providers. These tools ensure ease of use and accessibility, even for users with vision impairments or other limitations, delivering valuable real-world data.
Vision-Friendly Design:
Our surveys are optimized for users with vision impairment, featuring enhanced visibility and intuitive navigation.
Surveys in Multiple Languages:
We offer surveys in various languages, ensuring that our platform is accessible to a global user base.
Comprehensive & Adaptable:
BraincheX covers all standard survey assessments and is easily adaptable to individual solutions.
Discover the Core of Innovation with Medotrax's Cloud-solution
Experience the Medotrax solution — where technology meets trust, and data leads to discoveries. Our servers for digital cognitive assessments and surveys are hosted in the European Union, fully complying with EU GDPR, KRITIS, and C5 standards, ensuring the highest levels of data privacy, security, and regulatory compliance.
Seamless Data Journey:
Dive into an ecosystem where data collection, management, and analysis are not just tasks but a symphony of precision. Our advanced tools are designed to handle complex data with ease, ensuring that every insight is a step towards groundbreaking discoveries.
Intuitive User Experience:
Navigate with simplicity and clarity. Our user-friendly interface is crafted to transform intricate processes into intuitive experiences, making it accessible for users of all technical backgrounds.
Uncompromised Data Security:
In an era where data is invaluable, we uphold the highest standards of security. Your data's integrity and confidentiality are our utmost priority. Our robust measures ensure that every piece of information is protected like a fortress.
GDPR: A Promise of Privacy:
Respecting data privacy is not just a policy; it's our principle. Our solution is fully compliant with the General Data Protection Regulation (GDPR), assuring that every byte of data is treated with the respect and privacy it deserves.
Medotrax: Pioneering Innovation in Clinical Neurology
Proven Excellence in Clinical Research and Care
Medotrax was founded by leading experts in dementia diagnosis, treatment, and research, who recognized the critical need for a more personalized, data-driven approach to early dementia diagnosis using digital technology for cognitive testing and real-world data acquisition. Our team has a distinguished history in research and is committed to advancing the field by transforming traditional diagnostic methods into more efficient, digitally powered processes that significantly improve patient outcomes.
Harnessing Advanced Algorithms for Biomarker Development
In collaboration with the LMU University Hospital Memory Clinic, Medotrax is pioneering the development of digital biomarkers for early dementia diagnosis. This partnership is helping to enhance the precision and accessibility of diagnostic tools within the broader medical community, contributing to early and more accurate detection of dementia.
Our Collaborators
We are proud to partner with the Davos Alzheimer's Collaborative on the Accurate Diagnosis project, which focuses on early detection and treatment of Alzheimer's disease, addressing challenges like specialist wait times and inconsistent clinical protocols.
Our partnership with the LMU Klinikum, one of Europe’s leading medical centers, further strengthens our efforts, allowing us to integrate cutting-edge clinical research with innovative digital health solutions, ensuring the highest standards of medical excellence.
Contact Us:
Interested in Medotrax? Reach out to us using the form below or email us:
Medotrax GmbH
Gleißmüllerstr. 11a, München
BY, 80992, Germany
